Case-Based Roundtable Meetings Spotlight
Case-Based Roundtable Meetings Spotlight: May 2023
Case-Based Roundtable Meetings Spotlight: April 2, 2023
Case-Based Roundtable Meetings Spotlight: April 1, 2023
Case-Based Roundtable Meetings Spotlight: March 2, 2023
Volume: 6
Issue: 4
Case-Based Roundtable Meetings Spotlight: March 1, 2023
Volume: 6
Issue: 3
Case-Based Roundtable Meetings Spotlight: February 2023
Volume: 6
Issue: 2
Case-Based Roundtable Meetings Spotlight: January 2023
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
3
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
4
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
5